Dudediligence.

Silo Pharma, Inc

SILONASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$18,025Sep ’24$18,026Dec ’24$18,026Mar ’25$18,025Jun ’25$18,025Sep ’25$18,026Dec ’25$18,026Mar ’26
Net income, by quarter
−$928,814Sep ’24−$1.7MDec ’24−$1.0MMar ’25−$1.2MJun ’25−$1.1MSep ’25−$881,530Dec ’25−$1.6MMar ’26−$832,829Jun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on file$72,102$72,102$72,102$72,102
Gross profit$66,260$66,264$66,264$66,264$27,807
Operating income−$2.7M−$3.6M−$3.9M−$4.7M−$4.3M
Net income$3.9M−$3.9M−$3.7M−$4.4M−$4.2M
Operating cash flow−$2.3M−$3.5M−$3.2M−$3.8M−$4.7M
Cash$9.8M$11.4M$3.5M$3.9M$4.7M
Shares outstanding2.0M3.2M2.9M4.5M13.3M